Enzymes are globular proteins that act as biological catalysts, i.e. they speed up biochemical reactions without being consumed.
General catalytic scheme: (\text{Substrate} + \text{Enzyme} \;\rightarrow\; ES \;\rightarrow\; \text{Enzyme} + \text{Product})
Produced under genetic control (gene transcription → translation → enzyme), therefore cellular regulation of gene expression directly regulates enzyme abundance.
Learning Aims (module CH4006 – Biosciences I)
Explain enzyme structure/function and mechanism of catalysis.
Describe requirements for enzyme activity, factors influencing it, and strategies for regulation.
Clarify the role of enzymes inside biochemical/metabolic pathways, including feedback inhibition and energetic coupling.
Types of Biochemical Reactions Catalysed
Anabolic (biosynthetic) reactions
Form bonds, consume energy, build complex molecules.
Catalytic power – one molecule can process thousands of substrates per second.
Specificity – each enzyme typically recognises one (or a narrow set of) substrate(s) via precise chemical fit at the active site.
Reversibility – catalysts speed both forward and reverse directions equally; net direction depends on \Delta G and reactant/product concentrations.
Sensitivity to cellular conditions – protein conformation (hence activity) is affected by temperature, pH, ionic strength, etc.
Models of Enzyme–Substrate Interaction
Lock-and-Key model
Historical, simplistic. Substrate shape exactly complements rigid active site; once product released, enzyme unchanged.
Induced-Fit model (modern view)
Active site is flexible; initial binding triggers conformational change → tighter fit, optimally positions catalytic residues.
Enhances transition-state stabilisation.
How Active Sites Lower Activation Energy
Transition-state stabilisation – binding lowers energy of the transition state relative to substrates.
Orientation – brings two substrates together in correct spatial arrangement.
Induced strain – strains specific bonds (makes them less stable) promoting breakage/formation.
Micro-environment – provides optimal pH, polarity, or electrostatic landscape within active site (e.g. shielding from water).
Catalytic Cycle (stepwise)
Substrates diffuse into active site → form enzyme–substrate (ES) complex through weak interactions (H-bonds, electrostatics, Van der Waals).
Active site undergoes adjustments (induced fit).
Chemical reaction occurs; E_A lowered, substrates converted → products.
Products have lower affinity → released.
Enzyme active site re-opens, ready for next catalytic event (enzyme not consumed).
Nomenclature Conventions
Enzymes named after substrate/reaction + suffix “-ase”.
Sucrase – hydrolyses sucrose.
Proteases – hydrolyse peptide bonds in proteins.
Lipases – hydrolyse triglycerides/lipids.
Factors Affecting Enzyme Activity
Temperature
Reaction rate rises with temperature due to increased kinetic energy up to an optimum (often 35–40 °C for human enzymes); beyond that, denaturation drops activity sharply.
pH
Each enzyme has an optimum pH reflecting its environment (e.g. pepsin ≈ pH 2 in stomach; trypsin ≈ pH 8 in intestine).
Deviations alter ionisation of active-site residues, upsetting binding/catalysis.
Substrate concentration
At low [S], rate ∝ [S]; as [S] increases active sites saturate → maximum velocity V_{\text{max}} reached.
Cofactors & Coenzymes
Non-protein helpers essential for some enzymes.
Inorganic ions (Mg²⁺, Zn²⁺, Fe²⁺).
Coenzymes (organic, often vitamins: NAD⁺, FAD, CoA).
Prosthetic groups – tightly bound cofactors (e.g. haem).
Enzyme Kinetics (Michaelis–Menten)
Rate equation: V = \dfrac{V{\text{max}}[S]}{Km + [S]}
V = initial rate; V{\text{max}} = maximal rate at saturation; Km = [S] at \tfrac12 V{\text{max}} (indicator of substrate affinity: lower Km ⇒ higher affinity).
Graphical features
Hyperbolic approach to asymptote V_{\text{max}} as [S] → ∞.
Regulation & Control Strategies
Gene-level control – transcription/translation of enzyme gene turned on/off.
Post-translational modification – phosphorylation (adds \text{PO}_4^{3−}), methylation, acetylation alter activity or localisation.
Inhibitors
Irreversible – covalently attach, permanently inactivate (e.g. nerve gas on acetylcholinesterase).
Competitive – resemble substrate; bind active site; raise apparent K_m; overcome by high [S].
Non-competitive – bind allosteric site; decrease V{\text{max}} without changing Km.
Activators – small molecules or ions that increase activity (e.g. Ca²⁺ for protein kinase C).
Enzymes in Metabolic Pathways
Metabolic pathway = ordered sequence of enzyme-catalysed steps converting a starting molecule → product.
Each step’s product becomes next enzyme’s substrate.
Enables efficiency & regulation:
Coupling exergonic and endergonic reactions (e.g. ATP hydrolysis powers biosynthesis).
Spatial organisation: enzymes often form complexes or scaffold on membranes (e.g. glycolysis enzymes loosely associated in cytosol; ETC embedded in inner mitochondrial membrane).
Example Pathway Illustration
Starting molecule A \xrightarrow{\text{Enz 1}} B \xrightarrow{\text{Enz 2}} C \xrightarrow{\text{Enz 3}} D.
Loss of any enzyme blocks the chain → metabolic disease or alternative routing.
Feedback Inhibition (End-Product Inhibition)
A classic negative-feedback regulatory scheme ensuring resources aren’t wasted.
End product binds allosteric site on an early enzyme → conformational change → pathway slows/stops.
Dynamic: as product concentration falls, inhibitor dissociates, pathway resumes.
Specific Example – Isoleucine Biosynthesis
Pathway: threonine → … → isoleucine (multi-step)
Isoleucine (end product) acts as non-competitive inhibitor of enzyme 1 (threonine deaminase).
High [isoleucine] ⇒ binding frequency > threonine binding ⇒ pathway suppressed.
When demand increases (levels drop), inhibition relieved, flux restarts.
Key Takeaways & Broader Connections
Enzymes make life’s chemistry possible under mild conditions compatible with delicate biomolecules.
They integrate with cellular physiology via genetic regulation, post-translational modifications, and metabolic feedback loops.
Understanding enzyme kinetics and regulation underpins biotechnology, pharmacology (designing inhibitors), and clinical diagnostics (enzyme deficiencies, inborn errors of metabolism).